These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 2875547
1. Treatment of reflux esophagitis with histamine H2-receptor antagonists. Kishi S, Tsuzi Y, Matsumura M, Kakutani A, Ito S, Mori H. Tokushima J Exp Med; 1985 Dec; 32(3-4):65-70. PubMed ID: 2875547 [No Abstract] [Full Text] [Related]
3. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D. Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463 [Abstract] [Full Text] [Related]
4. H2 antagonists in the treatment of reflux esophagitis: a critical analysis. Stalnikowicz-Darvasi R. Am J Gastroenterol; 1989 Mar; 84(3):245-8. PubMed ID: 2563926 [Abstract] [Full Text] [Related]
5. Medical treatments in the short-term management of reflux esophagitis. Guirguis-Blake J. Am Fam Physician; 2008 Mar 01; 77(5):620. PubMed ID: 18350759 [No Abstract] [Full Text] [Related]
6. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials. Koelz HR. Scand J Gastroenterol Suppl; 1989 Mar 01; 156():25-36. PubMed ID: 2568015 [Abstract] [Full Text] [Related]
8. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage]. Vasil'ev IuV, Li IA. Eksp Klin Gastroenterol; 2002 Mar 01; (4):30-3, 131. PubMed ID: 12503271 [Abstract] [Full Text] [Related]
9. [Cimetidine versus ranitidine in the treatment of peptic esophagitis]. Noya G, Dettori G, Muscas A, Spirito R, Niolu P, Marongiu G, Biglioli P. Minerva Med; 1983 Apr 07; 74(14-15):787-90. PubMed ID: 6132354 [Abstract] [Full Text] [Related]
10. Treatment of gastroesophageal reflux: the role of proton pump inhibitors. Schulman MI, Orlando RC. Adv Intern Med; 1995 Apr 07; 40():273-302. PubMed ID: 7747649 [No Abstract] [Full Text] [Related]
11. [Medical treatment of gastroesophageal reflux in adults]. Cadiot G. Ann Gastroenterol Hepatol (Paris); 1996 Apr 07; 32(2):100-2. PubMed ID: 8737506 [No Abstract] [Full Text] [Related]
16. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group. Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE. Am J Gastroenterol; 1993 Aug 01; 88(8):1212-7. PubMed ID: 8101695 [Abstract] [Full Text] [Related]
17. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment. Bardhan KD, Cherian P, Jones RB, Vaishnavi A, Manek S, Bishop A, Polak J, Brooks A, Morris P, Thompson M, D'Silva J, Parkin S, Patterson J, Gillon KR. Ital J Gastroenterol Hepatol; 1997 Dec 01; 29(6):515-9. PubMed ID: 9513825 [Abstract] [Full Text] [Related]
18. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis. Hamamoto N, Hashimoto T, Adachi K, Hirakawa K, Ishihara S, Inoue H, Taniura H, Niigaki M, Sato S, Kushiyama Y, Suetsugu H, Miyake T, Kinoshita Y. J Gastroenterol Hepatol; 2005 Feb 01; 20(2):281-6. PubMed ID: 15683433 [Abstract] [Full Text] [Related]